** Cutera Inc's CUTR.O shares down 9.5% at $44.94 on very
light premarket volume as co raises capital
** Dermatology-focused firm prices 4.00% 7-yr convertible
senior notes urn:newsml:reuters.com:*:nBwJ02m1a
** Conversion price of $58.35 represents 17.5% premium to
stock's last close
** Co to use ~$21 mln of net offering proceeds to pay cost
of capped call transactions; remainder for general purposes,
including placements of AviClear, its laser treatment for acne
** Shares have gained 20% YTD through Weds for $974 mln
market cap, per Refinitiv
** All 5 analysts covering CUTR recommend buying the stock,
per Refinitiv, with $78 median PT
(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@thomsonreuters.com
lance.tupper@tr.com 1-332-219-1430))